Although BPC 157 has shown promising results in preclinical studies, further research and clinical trials need to be done in order to determine its potential therapeutic application and safety in humans
microscopic visualization of particles within the phagolysosome, increased lysosomal enzyme activity, and the requirement of specific receptors for internalization will serves as proof for MSUc uptake
Research involving the diet seems complicated
Learn more Tesamorelin Therapy FDA-approved GHRH analog that targets visceral fat reduction while boosting growth hormone levels
[PMID: 7923567] PubMed record related to this compound for laboratory literature review
Not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, food use, cosmetic use, or household use